BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 24145239)

  • 1. Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.
    Cheng Y; Li K; Diao D; Zhu K; Shi L; Zhang H; Yuan D; Guo Q; Wu X; Liu D; Dang C
    Lab Invest; 2013 Dec; 93(12):1276-87. PubMed ID: 24145239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.
    Zhang J; Yang X; Wang Y; Shi H; Guan C; Yao L; Huang X; Ding Z; Huang Y; Wang H; Cheng C
    Dig Dis Sci; 2013 Jul; 58(7):2028-37. PubMed ID: 23456497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
    Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP8 regulates cisplatin resistance through TAF-Iα and promotes malignant progression of esophageal cancer.
    Zhang DL; Yang N
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4775-4784. PubMed ID: 32432789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA‑216a‑5p suppresses esophageal squamous cell carcinoma progression by targeting KIAA0101.
    Sun T; An Q; Yan R; Li K; Zhu K; Dang C; Yuan D
    Oncol Rep; 2020 Nov; 44(5):1971-1984. PubMed ID: 32901882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KIAA0101 promotes cisplatin resistance through regulating cell apoptosis in lung cancer cells.
    Zhang C; Liu Y; Zhao J; Xu J; Pei B; Liu X; Yue X
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):172-176. PubMed ID: 38279448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells.
    Hummel R; Watson DI; Smith C; Kist J; Michael MZ; Haier J; Hussey DJ
    J Gastrointest Surg; 2011 Mar; 15(3):429-38. PubMed ID: 21246413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer.
    Lindner K; Borchardt C; Schöpp M; Bürgers A; Stock C; Hussey DJ; Haier J; Hummel R
    J Exp Clin Cancer Res; 2014 Sep; 33(1):73. PubMed ID: 25175076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
    Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
    J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma.
    Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
    Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of altered WIG-1 expression on DDP sensitivity in a DDP-resistant esophageal squamous cancer cell line.
    Qiu Y; Zou YB; Li K; Jiang YG; Yang K; Zhao YP; Guo W
    Curr Cancer Drug Targets; 2012 Oct; 12(8):950-61. PubMed ID: 22794122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA signatures in chemotherapy resistant esophageal cancer cell lines.
    Hummel R; Sie C; Watson DI; Wang T; Ansar A; Michael MZ; Van der Hoek M; Haier J; Hussey DJ
    World J Gastroenterol; 2014 Oct; 20(40):14904-12. PubMed ID: 25356050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene GAEC1 regulates CAPN10 expression which predicts survival in esophageal squamous cell carcinoma.
    Chan D; Tsoi MY; Liu CD; Chan SH; Law SY; Chan KW; Chan YP; Gopalan V; Lam AK; Tang JC
    World J Gastroenterol; 2013 May; 19(18):2772-80. PubMed ID: 23687414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
    Wu K; Yang Y; Zhao J; Zhao S
    Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
    Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
    Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stathmin is a marker of progression and poor prognosis in esophageal carcinoma.
    Wang F; Xuan XY; Yang X; Cao L; Pang LN; Zhou R; Fan QX; Wang LX
    Asian Pac J Cancer Prev; 2014; 15(8):3613-8. PubMed ID: 24870766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated expression of BIRC6 protein in non-small-cell lung cancers is associated with cancer recurrence and chemoresistance.
    Dong X; Lin D; Low C; Vucic EA; English JC; Yee J; Murray N; Lam WL; Ling V; Lam S; Gout PW; Wang Y
    J Thorac Oncol; 2013 Feb; 8(2):161-70. PubMed ID: 23287853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
    Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
    Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.